Factor XIII deficiency management
Update on von Willebrand factor multimers
Fibrinolysis in normal vitreous liquid
Comparison of platelet parameters in thrombocytopenic patients associated with acute myeloid leukemia and primary immune thrombocytopenia
Activity of thrombin-activatable fibrinolysis inhibitor in the plasma of patients with abdominal aortic aneurysm
Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio
The in-vitro anticoagulant effect of rivaroxaban in neonates
Poor prognosis of hypocoagulability assessed by thrombin generation assay in disseminated intravascular coagulation
Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer
Is tissue factor pathway inhibitor a marker of procoagulable status in healthy infertile women undergoing ovarian stimulation for assisted reproduction?
Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass
Outcomes of patients requiring insertion of an inferior vena cava filter
Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism
Interference from heterophilic antibodies in D-dimer assessment. A case report
Fibrinogen geneva II
Factor V deficiency caused by a novel nonsense mutation (Gln2031stop) in a Chinese patient
Testosterone, anastrozole, factor V Leiden heterozygosity and osteonecrosis of the jaws
Rituximab therapy for factor II inhibitor in a patient with antiphospholipid antibody syndrome
Influence of centrifuge brake on residual platelet count and routine coagulation tests in citrated plasma